Top Markets
Coin of the day
Drugs Made In America Acquisition Corp. Ordinary Shares Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA
Rank in Stocks #17037
Drugs Made In America Acquisition Corp. does not have significant operations.... Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Share Price
$10.75
Last synced: 2026-09-01
Market Cap
$260.98M
Change (1 day)
0.00%
Change (1 year)
4.78%
Country
US
Trade Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Revenue for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Revenue in Sep 2026 TTM: 0
According to Drugs Made In America Acquisition Corp. Ordinary Shares latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Drugs Made In America Acquisition Corp. Ordinary Shares from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors